FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

GSK chief says two buyout deals in works

GlaxoSmithKline (NYSE: GSK) CEO Andrew Witty (photo) plans to announce two "small" acquisitions soon, after walking away from five potential purchases or partnerships since October. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about GlaxoSmithKline   Mergers and Acquisitions   Andrew Witty